Department of Anesthesiology, Pain and Sleep Medicine, Aviation General Hospital of China Medical University and Beijing Institute of Translational Medicine, Chinese Academy of Sciences, Beijing, China.
Savaid Medical School, University of Chinese Academy of Science, Beijing, China.
J Clin Sleep Med. 2021 Aug 1;17(8):1737-1742. doi: 10.5664/jcsm.9310.
The authors present the clinical case of a 67-year-old man with severe insomnia for 5 years with an exacerbation about 1 year before consultation. He did not have enough concentration and energy for his daily work and developed depression and anxiety because of his excessive daytime sleepiness. During his insomniac state, a drug treatment provided partial relief, but the effects were not long-lasting. Consequently, the drug dosage increased, and major side effects gradually manifested. We decided to use a completely new therapeutic strategy for this patient to improve his sleep quality and mental symptoms. In time, the patient could stop oral medications and that is multimodal sleep. After the end of multimodal sleep, the patient typically experiences improvement in sleep quality and architecture. Additionally, the dosage of hypnotics used before multimodal sleep is discontinued without severe withdrawal symptoms.
Zhang J-F, Williams JP, Zhao Q-N, et al. Multimodal sleep, an innovation for treating chronic insomnia: case report and literature review. . 2021;17(8):1737-1742.
作者报告了 1 年前加重的、5 年严重失眠病史的 67 岁男性病例。他白天困倦,导致工作时注意力和精力均不足,进而出现抑郁和焦虑。失眠期间,药物治疗部分缓解,但效果不能持久,因此药物剂量逐渐增加,且出现了严重的不良反应。我们决定为该患者采用全新的治疗策略,以改善其睡眠质量和精神症状。最终,患者成功停用口服药物,实现多模式睡眠。多模式睡眠结束后,患者的睡眠质量和结构通常会得到改善,并且在停用多模式睡眠前使用的催眠药物剂量不会出现严重戒断症状。
Zhang J-F, Williams JP, Zhao Q-N, et al. Multimodal sleep, an innovation for treating chronic insomnia: case report and literature review.. 2021;17(8):1737-1742.